Cita APA

Eldehna, W. M., Al-Rashood, S. T., Al-Warhi, T., Eskandrani, R. O., Alharbi, A., & El Kerdawy, A. M. (2020). Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: Design, synthesis, biological evaluation, and in silico studies. J Enzyme Inhib Med Chem.

Chicago Style Citation

Eldehna, Wagdy M., Sara T. Al-Rashood, Tarfah Al-Warhi, Razan O. Eskandrani, Amal Alharbi, i Ahmed M. El Kerdawy. "Novel Oxindole/benzofuran Hybrids As Potential Dual CDK2/GSK-3β Inhibitors Targeting Breast Cancer: Design, Synthesis, Biological Evaluation, and in Silico Studies." J Enzyme Inhib Med Chem 2020.

Cita MLA

Eldehna, Wagdy M., et al. "Novel Oxindole/benzofuran Hybrids As Potential Dual CDK2/GSK-3β Inhibitors Targeting Breast Cancer: Design, Synthesis, Biological Evaluation, and in Silico Studies." J Enzyme Inhib Med Chem 2020.